Abstract:Objective: To summarize the clinical features and genetic characteristics of Congenital bile acid synthetic disorder type 3 (BASD3) disorder caused by CYP7B1 gene variation. Methods: This was a case series study. Clinical data and genetic results of 2 cases of congenital bile acid synthetic disorder type 3 caused by CYP7B1 gene variations in the Department of Infectious Diseases, Children's Hospital of Fudan University at Xiamen and Department of Pediatrics, Women and Children's Hospital, School of Medicine, Xiamen University from January 2021 to December 2023 were retrospectively collected and analyzed. Literature up to December 2023 was searched from electronic databases of China National Knowledge Infrastructure (CNKI), Wanfang Data and PubMed with the combined keywords of " Congenital bile acid synthetic disorder type 3""Oxysterol 7-alpha-hydroxylase""Oxysterol 7α-Hydroxylase Deficiency""BASD3" and "CYP7B1 liver" both in Chinese and English. The main clinical features and genetic characteristics of BASD3 disorder caused by CYP7B1 gene variations were summarized. Results: Two BASD3 patients, 1 male and 1 female, were admitted at the ages of 3 months and 18 days, and 2 months and 7 days, respectively. Both patients presented with neonatal cholestasis and hepatomegaly. Biochemical evidence indicated direct hyper-bilirubinemia with elevated aminotransferase levels, while gamma-glutamyltransferase (GGT) and total bile acid levels were normal or nearly normal. Patient 1 was a compound heterozygotes of the CYP7B1 gene variants c.525-526insCAAGTTGG(p.Asp176GInfs*15) and c.334C>T(p.Arg112Ter). Patient 1 jaundice resolved and liver function tests normalized after oral administration of chenodeoxycholic acid (CDCA). Patient 2 was homozygous for variant c.334C>T(p.Arg112Ter) in CYP7B1 gene. Patient 2 was in liver failure status already and not reactive to oral CDCA administration. Patient 2 received living-related liver transplantation for enhanced abdominal CT revealed a liver tumor likely vascular origin. Literature review revealed no cases of BASD3 reported in Chinese literature, including 2 patients in this study, while 12 patients (9 males and 3 females) were reported in 9 English literatures. All of the 12 manifested jaundice and hepatosplenomegaly in infancy, with cirrhosis, liver failure, kidney enlargement, hypoglycemia, and spontaneous bleeding in some cases, polycystic kidney disease was demonstrated in 5 cases of them. The c.334C>T (p.Arg112Ter) of the CYP7B1 gene was homozygous in 4 cases and compound heterozygous in 2 cases. Among the 12 children, 6 cases received CDCA treatment, while 6 cases not. Four survived with their native liver in the 6 cases who received CDCA therapy, while none in the 6 cases not received CDCA therapy. Conclusions: BASD3 is a rare hereditary cholestatic disorder. Markedly elevated levels of conjugated bilirubin and aminotransferases, with normal or nearly normal GGT and total bile acid levels can serve as diagnostic clue. c.334C>T is the most common pathogenic variant of the CYP7B1 gene. Timely administration of CDCA may save the liver.

Primary ∆4-3-oxosteroid 5Β-Reductase Deficiency: Two Cases in China

Recurrent AKR1D1 c.580-13T>A Variant: A Cause of Δ4-3-Oxosteroid-5β-Reductase Deficiency

Recurrent AKR1D1 c.580-13T>A Variant A Cause of D4-3-Oxosteroid-5b-Reductase Deficiency

Δ4-3-oxosteroid-5β-reductase deficiency: Responses to oral bile acid therapy and long-term outcomes.

Novel Phenotypes and Genotypes in Antley-Bixler Syndrome Caused by Cytochrome P450 Oxidoreductase Deficiency: Based on the First Cohort of Chinese Children

Infant cholestasis patient with a novel missense mutation in the AKR1D1 gene successfully treated by early adequate supplementation with chenodeoxycholic acid: A case report and review of the literature.

Recurrent AKR1D1 c.580-13T>A Variant

Genetic spectrum and clinical characteristics of 3β-hydroxy-Δ5-C27-steroid oxidoreductase (HSD3B7) deficiency in China

Differential Feedback Regulation of Δ4-3-Oxosteroid 5β-Reductase Expression by Bile Acids

Successful treatment of an infant with congenital bile acid synthesis disorder type 3 by ursodeoxycholic acid: a case report

Genetic Analysis of 25 Patients with 5Α-Reductase Deficiency in Chinese Population.

Identification of Three Novel SRD5A2 Mutations in Chinese Patients with 5Α-Reductase 2 Deficiency.

Clinical characteristics and molecular diagnosis in 2 cases of P450 oxidoreductase deficiency

[Clinical Feature and Genetic Analysis of a Family Affected by Congenital Bile Acid Synthesis Defect Type 2: Identification of 2 Novel Mutations in AKR1D1 Gene].

[Congenital bile acid synthetic disorder type 3 caused by CYP7B1 gene variation in 2 cases and literature review]

New, Recurrent, and Prevalent Mutations: Clinical and Molecular Characterization of 26 Chinese Patients with 17Alpha-Hydroxylase/17,20-lyase Deficiency.

Successful Treatment of Infantile Oxysterol 7Α-Hydroxylase Deficiency with Oral Chenodeoxycholic Acid.

Phenotypic and Molecular Characteristics in Eleven Chinese Patients with 5α‐reductase Type 2 Deficiency

Clinical Characteristics and Genetic Analysis in Two Patients with 3Β-Hydroxysteroid Dehydrogenase Deficiency

New Insights into 5Α-Reductase Type 2 Deficiency Based on a Multi-Centre Study: Regional Distribution and Genotype–phenotype Profiling Ofsrd5a2in 190 Chinese Patients

A Chinese patient with 11β-hydroxylase deficiency due to novel compound heterozygous mutation in CYP11B1 gene: a case report